HELIC2 Inhibitors

HELIC2 inhibitors are primarily conceptualized here as chemicals that indirectly affect the function of HELIC2, a protein involved in DNA repair and replication processes. Since direct inhibitors of HELIC2 are not well-established or identified, the focus is on compounds that modulate key proteins and enzymes in the DNA damage response and repair pathways, where HELIC2 plays a significant role.

These inhibitors target a range of proteins such as ATR, WEE1, CHK1, PARP, DNA-PKcs, ATM, and MRE11, which are crucial in maintaining genomic stability and responding to DNA damage. For instance, ATR inhibitors like VE-821 and AZD6738 function by impeding the kinase activity of ATR, a critical regulator in the cellular response to replication stress and DNA damage. This can indirectly impact HELIC2 activities, as HELIC2 is involved in similar pathways. Similarly, inhibitors targeting WEE1 (like MK-1775) and CHK1 (such as PF-477736 and AZD7762) disrupt the cell cycle checkpoints and DNA repair mechanisms, potentially influencing the functional context of HELIC2. PARP inhibitors, notably Olaparib, play a significant role in hampering DNA repair processes, particularly in cancer cells. By inhibiting PARP enzymes, these compounds indirectly affect pathways where HELIC2 is involved. DNA-PKcs and ATM inhibitors, like NU7441 and KU-55933 respectively, are crucial in non-homologous end joining and homologous recombination repair pathways. Their inhibition can have a cascading effect on HELIC2's role in these pathways. Additionally, compounds like Mirin and CGK733, which target MRE11 and both ATM and ATR, further exemplify the strategy of indirect inhibition impacting HELIC2's function.